Gravesano, November 2018
Cell Culture Technologies inks technical assistance agreements with global health care companies
We are glad to announce the signing of technology transfer agreements that allow health care companies access to our unique SteMaxOne Program, a set of high-tech activities including material and methods for the development of chemically defined in vitro nutrition for stem cell culture directly at the customer’s premises.
Based on the success of the ChoMaster System, the technology platform for the production of recombinant glycoproteins in chemically defined minimal culture media, we launched the SteMaxOne Program in order to help health care companies implementing our know-how regarding development of in vitro nutrition for translational research. Particularly, the technology transfer Program focuses on the generation of human stem cells and extracellular nanovesicles from several cell types in chemically defined nutrient mixtures.
A new set of custom-made culture media
We added 13 new custom-made media formulations to our specialty media collection as requested by research groups located in Basel, Berlin, Duesseldorf, Heidelberg, Loughborough, Melbourne, Nottingham, Seoul, Tromsø, Vienna and Zurich. Are you looking for a modified medium formulation for translational medicine research?